NCT00440778View on ClinicalTrials.gov

A Randomized Trial of Early Discharge After Trans-radial Stenting of Coronary Arteries in Acute MI

PHASE4CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Myocardial InfarctionIschemia
Interventions
DRUG

Abciximab

100% abciximab bolus dose (0.3 mg/kg) ic or iv vs standard bolus (0.25 mg/kg) ic or iv plus 12-hr infusion

Trial Locations (1)

G1V 4G5

Laval Hospital, Québec

Sponsors

Collaborators (1)

Cordis Corporation
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

collaborator

Cordis Corporation

INDUSTRY

collaborator

Quebec Heart Institute

OTHER

lead

Laval University

OTHER